Search for content, post, videos

GPX Medical sells its first NEOLA system

Hanna Sjöström Photo Roger Nellsjö

The company has Sold its First NEOLA System to Tyndall National Institute at University College Cork to be used for a large study on newborn infants within the Irish Centre for Maternal and Child Health Research in Ireland.

Tyndall National Institute at University College Cork in Ireland (UCC) will aquire a NEOLA system from GPX Medical in order to launch a large study on newborn infants at the research facility at Cork University Maternity Hospital, the company states in a press release. This study will be conducted in cooperation with the Irish Centre for Maternal and Child Health Research (INFANT) at UCC.

Read more: Hey there: Hanna Sjöström, CEO, GPX Medical

A non-commercial version

The commercial value of the agreement is estimated to 60,000 EUR.

The NEOLA system that UCC will acquire is a non-commercial version of GPX Medical’s medical device for continuous lung monitoring and has gone through an extensive two-year process to now safely be used in a clinical study.

”This cooperation marks not only our first sale of the NEOLA® system but will also be significant in validating our technology through the study that UCC will initiate. INFANT and Tyndall at UCC are both highly respected research organizations. The study will give us extensive insights and data, which will be valuable in our product development and validation process going forward,” says Hanna Sjöström, CEO of GPX Medical.

About the study

The study that UCC will initiate is planned to encompass approximately 200 infants, starting with healthy newborns and then follow with newborns with different types of breathing problems and with infants within different weight classes. The study is scheduled to start in the autumn of 2021. More precisely the study will evaluate positioning the probes on different areas of on the infants’ chests. The principal investigator of the study is Professor Eugene Dempsey, Horgan Chair in Neonatology, INFANT Centre, University College Cork (UCC), supported by the BioPhotonics team at Tyndall.

“Implementing better methods of monitoring the lung function of preterm born infants is needed. Today, neonatal health care professionals treating children being born preterm must rely on manual observation with help from chest x-rays and blood samples predominantly,” says Research Fellow Jurate Panaviene, INFANT Centre, UCC and Cork University Maternity Hospital.

Photo of Hanna Sjöström: Roger Nellsjö